Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.

ADCs can potentially expand the range of effective therapies while minimizing toxicity to healthy tissues, especially in refractory cancer.

IGF2BP3 links cancer metabolism and RNA control, offering a potential new therapeutic target for blocking leukemia cell growth.

Researchers are now exploring how different types of repetitive DNA create genome instability and structurally variant chromosomes.

Officials at Concept Life Sciences say the company’s headquarters is now one of the U.K.’s largest drug discovery research sites.

Researchers say findings could lead to breakthroughs in tissue repair and regenerative medicine, as well as advanced medical ...

David Baker’s Nobel Prize-winning lab has designed protein on/off switches as a tool for tunable cancer immunotherapies and biosensors.

Lonza says it provides services ranging from early phase development to full-scale commercial manufacturing at the St. Petersburg site.

Antibody purification evolves with diverse formats, driving tailored chromatography solutions for efficiency, scalability, ...

RION officials say the company developed a proprietary biomanufacturing platform enabling scaled production of platelet-derived exosomes. This platform allows for the advancement of RION’s pipeline of ...

Consistently-sized nano-scale lipopolyplex nonviral vectors were created in a microfluidics system for DNA delivery.